This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

KEYTRUDA® (pembrolizumab) KEYNOTE-177 clinical data presentation

KEYNOTE-177 metastatic Colorectal Cancer (CRC) slide deck providing information on study design, trial endpoints, efficacy and safety.

More information about KEYTRUDA® (pembrolizumab) in metastatic CRC

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-OVA-00009 | Date of Preparation: April 2021